Annual Results Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
13.56
12.71
12.71
15.26
12.22
12.22
Share Warrants & Outstandings
Total Reserve
253.37
200.34
194.27
178.16
134.25
120.67
Shareholder's Funds
275.55
213.05
206.98
193.41
146.47
132.89
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
6.15
3.73
1.26
0.87
5.07
6.40
Secured Loans
3.35
3.73
1.26
0.87
5.07
6.40
Unsecured Loans
2.80
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-3.17
-2.83
-2.51
-1.88
-0.50
0.28
Other Long Term Liabilities
0
0
0
0
0
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.37
2.20
1.76
1.66
1.46
1.16
Total Non-Current Liabilities
5.35
3.11
0.50
0.65
6.04
7.84
Current Liabilities
Trade Payables
40.01
42.65
38.95
47.59
43.30
32.21
Other Current Liabilities
5.06
4.79
15.12
10.98
9.29
9.50
Short Term Borrowings
41.63
29.52
29.56
23.31
19.27
10.93
Short Term Provisions
1.23
1.20
0.92
0.69
0.82
0.63
Total Current Liabilities
87.92
78.16
84.56
82.57
72.69
53.27
Total Liabilities
368.82
294.32
292.04
276.64
225.20
194.01
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
143.55
138.78
136.70
130.43
124.26
115.66
Less: Accumulated Depreciation
58.89
51.67
44.85
37.77
31.78
26.02
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
84.66
87.10
91.85
92.66
92.48
89.64
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
4.96
1.24
1.22
1.11
0.87
0.78
Other Non Current Assets
55.47
41.42
39.37
19.51
8.82
7.56
Total Non-Current Assets
145.09
129.77
132.44
113.28
102.16
97.97
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
70.08
62.14
59.38
45.06
27.01
5.20
Sundry Debtors
81.83
68.90
55.26
65.26
63.22
52.55
Cash and Bank
31.26
3.76
14.79
20.78
3.82
3.89
Other Current Assets
1.82
2.52
22.17
21.98
19.55
22.52
Short Term Loans and Advances
38.74
27.24
8.00
10.29
9.43
11.87
Total Current Assets
223.73
164.55
159.59
163.36
123.04
96.03
Net Current Assets (Including Current Investments)
135.81
86.39
75.04
80.79
50.35
42.76
Total Current Assets Excluding Current Investments
223.73
164.55
159.59
163.36
123.04
96.03
Miscellaneous Expenses not written off
6.65
6.78
6.70
7.06
7.74
6.66
Total Assets
368.82
294.32
292.04
276.64
225.20
194.01
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
47.78
33.25
30.82
24.18
24.35
17.33
Book Value per share (adjusted)
196.82
167.57
162.79
150.82
119.89
108.78
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 43.70% vs 7.88% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -2.80% vs -5.17% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 35.96% vs 3.11% in Mar 2025
Compare Balance Sheet Results of Medicamen Biotec
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.56
0
13.56
0.00%
Share Warrants & Outstandings
Total Reserve
253.37
0
253.37
0.00%
Shareholder's Funds
275.55
0
275.55
0.00%
Minority Interest
0.00
0
0.00
0.00%
Long-Term Borrowings
6.15
0
6.15
0.00%
Secured Loans
3.35
0
3.35
0.00%
Unsecured Loans
2.80
0
2.80
0.00%
Deferred Tax Assets / Liabilities
-3.17
0
-3.17
0.00%
Other Long Term Liabilities
0.00
0
0.00
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
2.37
0
2.37
0.00%
Total Non-Current Liabilities
5.35
0
5.35
0.00%
Current Liabilities
Trade Payables
40.01
0
40.01
0.00%
Other Current Liabilities
5.06
0
5.06
0.00%
Short Term Borrowings
41.63
0
41.63
0.00%
Short Term Provisions
1.23
0
1.23
0.00%
Total Current Liabilities
87.92
0
87.92
0.00%
Total Liabilities
368.82
0
368.82
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
143.55
0
143.55
0.00%
Less: Accumulated Depreciation
58.89
0
58.89
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
84.66
0
84.66
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
0.00
0
0.00
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.00
0
0.00
0.00%
Long Term Loans & Advances
4.96
0
4.96
0.00%
Other Non Current Assets
55.47
0
55.47
0.00%
Total Non-Current Assets
145.09
0
145.09
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
70.08
0
70.08
0.00%
Sundry Debtors
81.83
0
81.83
0.00%
Cash and Bank
31.26
0
31.26
0.00%
Other Current Assets
1.82
0
1.82
0.00%
Short Term Loans and Advances
38.74
0
38.74
0.00%
Total Current Assets
223.73
0
223.73
0.00%
Net Current Assets (Including Current Investments)
135.81
0
135.81
0.00%
Total Current Assets Excluding Current Investments
223.73
0
223.73
0.00%
Miscellaneous Expenses not written off
6.65
0
6.65
0.00%
Total Assets
368.82
0
368.82
0.00%
Contingent Liabilities
0.00
0
0.00
0.00%
Total Debt
47.78
0
47.78
0.00%
Book Value per share (adjusted)
196.82
0
196.82
0.00%
Annual - Borrowings
Borrowings 47.78 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 43.70% vs 7.88% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 84.66 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.80% vs -5.17% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 223.73 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 35.96% vs 3.11% in Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
